PolyPid Ltd
PYPD3.970USD
+0.050+1.28%
收盤 12/19, 16:00（美東）報價延遲15分鐘
66.04M總市值
虧損本益比TTM
關於 PolyPid Ltd 公司
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
PolyPid Ltd簡介
公司代碼PYPD
公司名稱PolyPid Ltd
上市日期Jun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
員工數量57
證券類型Ordinary Share
年結日Jun 26
公司地址18 Hasivim Street, P.O Box 7126
城市PETAH TIKVA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編4917002
電話972747195700
網址https://www.polypid.com
公司代碼PYPD
上市日期Jun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
PolyPid Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
+100.00%
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Mr. Chaim Hurvitz
Mr. Chaim Hurvitz
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Robert Burton (Bob) Stein, M.D., Ph.D.
Dr. Robert Burton (Bob) Stein, M.D., Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
+100.00%
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Mr. Chaim Hurvitz
Mr. Chaim Hurvitz
Independent Director
Independent Director
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Aurum Ventures M.K.I.
18.53%
Centaurus Investments Limited
6.66%
Rosalind Advisors, Inc.
5.52%
AIGH Capital Management, LLC.
4.64%
Nir (Yehuda)
3.69%
其他
60.96%
持股股東
持股股東
佔比
Aurum Ventures M.K.I.
18.53%
Centaurus Investments Limited
6.66%
Rosalind Advisors, Inc.
5.52%
AIGH Capital Management, LLC.
4.64%
Nir (Yehuda)
3.69%
其他
60.96%
股東類型
持股股東
佔比
Venture Capital
18.66%
Hedge Fund
10.77%
Holding Company
6.66%
Individual Investor
5.52%
Private Equity
4.64%
Corporation
3.53%
Investment Advisor/Hedge Fund
1.76%
Research Firm
1.36%
Investment Advisor
1.22%
其他
45.87%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
28
6.76M
43.18%
+2.23M
2025Q2
41
7.60M
74.58%
+1.39M
2025Q1
42
7.66M
75.16%
+942.60K
2024Q4
44
5.48M
65.20%
+1.87M
2024Q3
50
4.47M
69.98%
+1.49M
2024Q2
58
3.43M
73.51%
+1.59M
2024Q1
59
3.33M
71.29%
+2.56M
2023Q4
54
443.78K
34.10%
+80.67K
2023Q3
57
479.04K
37.01%
+97.48K
2023Q2
57
472.86K
36.65%
+91.51K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Aurum Ventures M.K.I.
3.08M
19.69%
+1.06M
+52.19%
Jun 30, 2025
Centaurus Investments Limited
1.11M
7.08%
+475.10K
+75.12%
Dec 31, 2024
Rosalind Advisors, Inc.
975.46K
6.23%
-42.56K
-4.18%
Jun 30, 2025
AIGH Capital Management, LLC.
462.54K
2.95%
-48.41K
-9.47%
Jun 30, 2025
Nir (Yehuda)
613.91K
3.92%
+62.60K
+11.36%
Mar 31, 2025
Hewlett Fund, L.P.
587.92K
3.76%
+338.44K
+135.66%
Feb 26, 2025
Triple Gate Capital, LP
465.84K
2.98%
+465.84K
--
Feb 26, 2025
Lukach (Aharon)
299.55K
1.91%
-5.64K
-1.85%
Mar 31, 2025
Worth Venture Partners, LLC
731.57K
4.67%
+302.14K
+70.36%
Jun 30, 2025
Dafna Capital Management, LLC
207.90K
1.33%
-83.37K
-28.62%
Jun 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
公告日期
類型
比率
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
Aug 30, 2023
Merger
30→1
常見問題
PolyPid Ltd的前五大股東是誰？
PolyPid Ltd的前五大股東如下：
Aurum Ventures M.K.I.持有股份：3.08M佔總股份比例：19.69%。
Centaurus Investments Limited持有股份：1.11M佔總股份比例：7.08%。
Rosalind Advisors, Inc.持有股份：975.46K佔總股份比例：6.23%。
AIGH Capital Management, LLC.持有股份：462.54K佔總股份比例：2.95%。
Nir (Yehuda)持有股份：613.91K佔總股份比例：3.92%。
Aurum Ventures M.K.I.持有股份：3.08M佔總股份比例：19.69%。
Centaurus Investments Limited持有股份：1.11M佔總股份比例：7.08%。
Rosalind Advisors, Inc.持有股份：975.46K佔總股份比例：6.23%。
AIGH Capital Management, LLC.持有股份：462.54K佔總股份比例：2.95%。
Nir (Yehuda)持有股份：613.91K佔總股份比例：3.92%。
PolyPid Ltd的前三大股東類型是什麼？
PolyPid Ltd 的前三大股東類型分別是：
Aurum Ventures M.K.I.
Centaurus Investments Limited
Rosalind Advisors, Inc.
Aurum Ventures M.K.I.
Centaurus Investments Limited
Rosalind Advisors, Inc.
有多少機構持有PolyPid Ltd(PYPD)的股份？
截至2025Q3，共有28家機構持有PolyPid Ltd的股份，合計持有的股份價值約為6.76M，占公司總股份的43.18% 。與2025Q2相比，機構持股有所增加，增幅為-31.40%。
哪個業務部門對PolyPid Ltd的收入貢獻最大？
在--，--業務部門對PolyPid Ltd的收入貢獻最大，創收--，占總收入的--% 。
